New synthetic biosensors developed by Professor Josh Leonard give immune cells the ability to read their environment and act ...

Although infection prevention is an essential part of every rheumatologist’s routine, balancing efficacy, risk and individual patient choices — all while contending with a seemingly constant flow of ...

Maternal inflammation during pregnancy influences fetal immune development and heightens the child’s risk of allergic conditions. Placental inflammation enhances fetal immune memory leading to ...

LONDON, GREATER LONDON, UNITED KINGDOM, August 21, 2025 /EINPresswire.com/ -- What Is The Projected Market Size & Growth Rate Of The Connective Tissue Disease Treatment Market? The market dedicated to ...

A recent paper has shed more light on how corticosteroids frequently prescribed to lung cancer patients could inhibit the ...

Sanofi has received orphan designation from the European Medicines Agency (EMA) for rilzabrutinib, a reversible covalent ...

Basel: Novartis has announced positive top-line results from VAYHIT2, a Phase III trial evaluating ianalumab plus eltrombopag ...

A world-first clinical trial led by Uppsala University Hospital has shown that gene-edited donor islet cells can survive and ...

EMA grants orphan designation to Sanofi’s rilzabrutinib, a reversible covalent BTK inhibitor, for IgG4-related disease: Paris Saturday, August 16, 2025, 09:00 Hrs [IST] Sanofi a ...

Researchers have discovered that neurons in the gut play a direct role in guiding immune healing after inflammation by ...

A medication often prescribed to reduce symptoms among people with lung cancer limits the effectiveness of certain treatments ...

Novartis' ianalumab plus eltrombopag significantly extended treatment response and improved platelet counts in a Phase 3 ...